海金沙가 Rat의 전립선비대에 미치는 영향
The Effects of Lygodium japonicum on Experimental Rat Model of Benign Prostatic Hyperplasia
2
조회
0
다운로드
4
인용
0
참고문헌
키워드
초록
Objective : In benign prostatic hyperplasia, dihydrotestosterone acts as a potent cellular androgen and promotes prostate growth. Inhibiting enzyme 5α-reductase that is involved in the conversion of testosterone to the active form dihydrotestosterone reduces this excessive prostate growth. The mechanism on benign prostatic hyperplasia is substantiating evidence to support the clinical value in the evaluation of therapeutic efficacy. In this study, we investigated the effects of Lygodium japonicum on cyto-pathological alterations and expression of 5α-reductase in the rat model of benign prostatic hyperplasia induced by castration and testosterone treatment. Methods : Sprague-Dawley rats were treated with testosterone after castration for induction of experimental benign prostatic hyperplasia, which is similar to human benign prostatic hyperplasia in histopathological profiles. Lygodium japonicum as an experimental specimen, and finasteride as a positive control, were administered orally. The prostates were evaluated by histopathological changes and testosterone levels. Also, the prostates were observed by hematological alterations of AST, ALT, γ-GTP, BUN and creatinine. Results : The rats treated with Lygodium japonicum showed a diminished range of luminal cell and duct epithelial cell damage. The stromal elements and connective tissue proliferation of Lygodium japonicum treated group as compared to the control group decreased. Conclusions : These findings suggest that Lygodium japonicum may protect the glandular epithelial cells. We concluded that Lygodium japonicum could be a useful remedy agent for treating the benign prostatic hyperplasia.
Abstract
Objective : In benign prostatic hyperplasia, dihydrotestosterone acts as a potent cellular androgen and promotes prostate growth. Inhibiting enzyme 5α-reductase that is involved in the conversion of testosterone to the active form dihydrotestosterone reduces this excessive prostate growth. The mechanism on benign prostatic hyperplasia is substantiating evidence to support the clinical value in the evaluation of therapeutic efficacy. In this study, we investigated the effects of Lygodium japonicum on cyto-pathological alterations and expression of 5α-reductase in the rat model of benign prostatic hyperplasia induced by castration and testosterone treatment. Methods : Sprague-Dawley rats were treated with testosterone after castration for induction of experimental benign prostatic hyperplasia, which is similar to human benign prostatic hyperplasia in histopathological profiles. Lygodium japonicum as an experimental specimen, and finasteride as a positive control, were administered orally. The prostates were evaluated by histopathological changes and testosterone levels. Also, the prostates were observed by hematological alterations of AST, ALT, γ-GTP, BUN and creatinine. Results : The rats treated with Lygodium japonicum showed a diminished range of luminal cell and duct epithelial cell damage. The stromal elements and connective tissue proliferation of Lygodium japonicum treated group as compared to the control group decreased. Conclusions : These findings suggest that Lygodium japonicum may protect the glandular epithelial cells. We concluded that Lygodium japonicum could be a useful remedy agent for treating the benign prostatic hyperplasia.
참고문헌 (22)
- 대한비뇨기과학회, "비뇨기과학", pp.311~315 (2008), 일조각
- 대한일차의료학회, "일차진료지침", pp.530~536, 한우리
- 대한가정의학과 개원의협의회, "질환별 환자관리 지침", pp.55~456 (2003), 한우리
- Miano R, "Treatment options for benign prostatic hyperplasia in older men", Med Sci Monit, 14(7), pp.94~102 (2008)
- Jacobsen SJ, "Natural history of benign prostatic hyperplasia", Urology, 58, pp.5~16 (2001)
- Carson C, "The role of dihydrotestosterone in benign prostatic hyperplasia", Urology, 62, pp.2~7 (2003)
- Stoner E, "The clinical development of a 5α- reductase inhibitor", J Steroid Biochem Mol Biol., 37, pp.375~378 (1990)
- 대한남성과학회, "남성과학", pp.557~565 (2003), 군자출판사
- 전국의과대학교수, "오늘의 진단 및 치료", pp.1018~1022 (2000), 한우리
- 두호경, "東醫腎系學", pp.705~708 (2003), 성보사
- 김철중, "癃閉의 治法 治方 및 外治法에 對한 文獻的 考察", 惠和醫學 학술지, pp.7~25 (2000)
- 한의과대학 본초학 편찬위원회, "본초학", pp.362~363 (2004), 영림사
- 김진성, "黃芩이 前立腺肥大症 Rat에 미치는 영향", 대한한방내과학회지, 30(2), pp.327~337 (2009), 대한한방내과학회
- 이상헌, "薑黃이 고환절제술 및 testosterone으로 유발된 rat의 전립선비대증에 미치는 영향", 대한한방내과학회지, 30(2), pp.355~364 (2009), 대한한방내과학회
- 이원덕, "인체해부생리학", pp.890~891 (2004), 정담
- Bartsch G, "Dihydrotestosterone and the concept of 5α- reductase inhibition in human benign prostatic hyperplasia", World J Urol, 19, pp.413~425 (2002)
- Cabelin MA, "Benign prostatic hyperplasia, challenges for the new millennium", Curr Opin Urol., 10, pp.301~306 (2000)
- Shapiro E, "Pathophysiology of clinical BPH", UCNA, 22, pp.285~290 (1995)
- Herbert Lepor, "Alpha Blockers for the Treatment of Benign Prostatic Hyperplasia", Rev Urol, 9(4), pp.181~190 (2007)
- Li S, "Bencao-gangmu", pp.579~580 (1992), Orient Publishing Co
- 이병철, "해금사가 만성 비세균성 전립선염 모델에서 혈액학적 및 세포조직학적 변화에 미치는 영향", 대한한방내과학회지, 27(3), pp.664~676 (2006), 대한한방내과학회
- 이귀녕, "임상병리파일 제3판", pp.367~370 (2000), 의학문화사